Role of Kiratatikta Churna in the management of Amavata(Rheumatoid Arthritis)

A Clinico-Etiopathological Study to evaluate the efficacy of Kiratatikta Churna in the management of Amavata - A Single arm clinical Trial

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/05/052849

Enrollment

Registered

2023-05-18

Start date

Unknown

Completion date

Unknown

Last updated

2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M069- Rheumatoid arthritis, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed Patients Of Rheumatoid Arthritis as per 2010 ACR/ EULAR Criteria Patients having Samanyalakshana and Pravridhhalakshana of Amavata as per Madhavnidana Patients willing to give consent for the study

Exclusion criteria

Exclusion criteria: Pregnant women and Lactating mothers All other forms of Arthritis Patients having co morbidities

Design outcomes

Primary

Measure	Time frame
Reduction in VAS score and DAS28 Score is expected and will be assessed on 0, 15th, 30th and 45th day.Timepoint: 45 Days	—

Secondary

Measure	Time frame
The study will provide cost effective, safe drug with lesser side effectsTimepoint: 6 months	—

Countries

India

Contacts

Public ContactProf Dr Vidula Gujjarwar

Chaudhary Brahm Prakash Ayurved Charak Sansthan, Khera Dabar, Najafgarh , New Delhi-110073

Shreemahalaxmi1969@gmail.com

Outcome results